Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Srinivas

Showing results (451-460 of 935) with videos related to

Pageof 94
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|October 31, 2015
Retrospective and Prospective Human Intravenous and Oral Pharmacokinetic Projection of Dipeptidyl peptidase-IV Inhibitors Using Simple Allometric Principles - Case Studies of ABT-279, ABT-341, Alogliptin, Carmegliptin, Sitagliptin and VildagliptinRavindranath R Gilibili, Ravi Kanth Bhamidipati, Ramesh Mullangi, et al.
Injury|February 16, 2005
Gunshot injuries to the extremities: experience of a U.K. trauma centreI J Persad, R Srinivas Reddy, M A Saunders, et al.
Rapid Communications in Mass Spectrometry : RCM|May 4, 2018
Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation productsC Purna Chander, B Raju, M Ramesh, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2011
Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS methodB Raju, M Ramesh, R Srinivas, et al.
International Journal of Mass Spectrometry|October 4, 2011
Deprotonated N-(2,4-Dinitrophenyl)amino Acids Undergo Cyclization in Solution and the Gas PhaseM George, V Ramesh, R Srinivas, et al.
Circulation|July 11, 2018
Trends in Apolipoprotein B, Non-High-Density Lipoprotein, and Low-Density Lipoprotein for Adults 60 Years and Older by Use of Lipid-Lowering Medications: United States, 2005 to 2006 Through 2013 to 2014Margaret D Carroll, Michael E Mussolino, Michael Wolz, et al.
European Journal of Drug Metabolism and Pharmacokinetics|November 18, 2016
Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and ZopiclonePoonam Giri, Sneha Naidu, Nirmal Patel, et al.
Rapid Communications in Mass Spectrometry : RCM|December 7, 2005
New experiments on HNCSe and HCNSe radical cationsP Gerbaux, N Dechamps, R Flammang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 13, 2006
Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF?S Mustafa, P Venkatesh, K Pasha, et al.
European Journal of Drug Metabolism and Pharmacokinetics|May 8, 2007
Preclinical pharmacokinetics and interspecies scaling of ragaglitazar, a novel biliary excreted PPAR dual activatorVenkata V Pavankuamr, C A Vinu, Ramesh Mullangi, et al.
Pageof 94

Showing results (451-460 of 935) with videos related to

Sort By:
Pageof 94
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|October 31, 2015
Retrospective and Prospective Human Intravenous and Oral Pharmacokinetic Projection of Dipeptidyl peptidase-IV Inhibitors Using Simple Allometric Principles - Case Studies of ABT-279, ABT-341, Alogliptin, Carmegliptin, Sitagliptin and VildagliptinRavindranath R Gilibili, Ravi Kanth Bhamidipati, Ramesh Mullangi, et al.
Injury|February 16, 2005
Gunshot injuries to the extremities: experience of a U.K. trauma centreI J Persad, R Srinivas Reddy, M A Saunders, et al.
Rapid Communications in Mass Spectrometry : RCM|May 4, 2018
Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation productsC Purna Chander, B Raju, M Ramesh, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2011
Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS methodB Raju, M Ramesh, R Srinivas, et al.
International Journal of Mass Spectrometry|October 4, 2011
Deprotonated N-(2,4-Dinitrophenyl)amino Acids Undergo Cyclization in Solution and the Gas PhaseM George, V Ramesh, R Srinivas, et al.
Circulation|July 11, 2018
Trends in Apolipoprotein B, Non-High-Density Lipoprotein, and Low-Density Lipoprotein for Adults 60 Years and Older by Use of Lipid-Lowering Medications: United States, 2005 to 2006 Through 2013 to 2014Margaret D Carroll, Michael E Mussolino, Michael Wolz, et al.
European Journal of Drug Metabolism and Pharmacokinetics|November 18, 2016
Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and ZopiclonePoonam Giri, Sneha Naidu, Nirmal Patel, et al.
Rapid Communications in Mass Spectrometry : RCM|December 7, 2005
New experiments on HNCSe and HCNSe radical cationsP Gerbaux, N Dechamps, R Flammang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 13, 2006
Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF?S Mustafa, P Venkatesh, K Pasha, et al.
European Journal of Drug Metabolism and Pharmacokinetics|May 8, 2007
Preclinical pharmacokinetics and interspecies scaling of ragaglitazar, a novel biliary excreted PPAR dual activatorVenkata V Pavankuamr, C A Vinu, Ramesh Mullangi, et al.
Pageof 94